Mostrando 10 resultados de: 10
Filtros aplicados
Publisher
American Journal of Therapeutics(4)
Revista Latinoamericana de Hipertension(3)
Anales de Medicina Interna(1)
Indian Journal of Gastroenterology(1)
Journal of Diabetes Research(1)
Área temáticas
Enfermedades(7)
Farmacología y terapéutica(3)
Salud y seguridad personal(3)
Medicina forense; incidencia de enfermedades(2)
Medicina y salud(2)
Changes in the severity of gastric mucosal inflammation associated with Helicobacter pylori in humans coinfected with intestinal helminths
ArticleAbstract: Background: Though a few studies in animal models suggest that intestinal helminths (IH) favorably aPalabras claves:Cytokine, Gastric Cancer, Gastropathy, Immune response, Immunohistochemical staining, interleukinsAutores:Álvarez-Mon M., Arismendi-Morillo G., Fuenmayor-Boscán A., Hernández-Rincón I., Lizarzabal M.I., Mengual-Moreno E., Romero G., Zulbey Ch Rivero-RodríguezFuentes:scopusCiprofibrate treatment decreases non-high density lipoprotein cholesterol and triglycerides and increases high density lipoprotein cholesterol in patients with frederickson type IV dyslipidemia phenotype
Conference ObjectAbstract: OBJECTIVE: The combination of hypertriglyceridemia and low high density lipoprotein (HDL) cholesteroPalabras claves:Ciprofibrate, Frederickson's type IV dyslipidemia, High density lipoprotein cholesterol, Hyperlipidemia, Low density lipoprotein cholesterol, Non-high density lipoprotein cholesterol, TriglyceridesAutores:Arráiz N., Bermúdez-Arias F., Cano-Peñaloza R., Cano-Ponce C., Contreras F., de Bravo M.C., De Diaz A.A., De Pirela N.L., Israili Z.H., Leal-Gonzalez E., Lemus-Antepaz M., Mengual-Moreno E., Puche-Medina G., Reyna-Villazmil N., Souki-Rincón A., Valasco M., Valmore BermúdezFuentes:scopusBiologic Behavior and optimal cut-off point estimation for Serum Fasting Insulin: A report from the Maracaibo City Metabolic Syndrome Prevalence Study
ArticleAbstract: Introduction: Insulin resistance is a metabolic state in which tissue effects of insulin are diminisPalabras claves:Cut-off point, hyperinsulinemia, Insulin, Insulin Resistance, Metabolic syndromeAutores:Amell A., Arráiz N., Calvo M.J., Carem Prieto, Chávez C., Chávez-Castillo M., David A., Escalona C., Gómez M.C., Lubo A., Martínez M.S., Mengual-Moreno E., Rojas-Quintero J., Romero J., Salazar-Vílchez J., Toledo A., Valero P., Valmore Bermúdez, Velasco M.Fuentes:googlescopusAn elevated level of physical activity is associated with normal lipoprotein(a) levels in individuals from Maracaibo, Venezuela
ArticleAbstract: Coronary artery disease is the main cause of death worldwide. Lipoprotein(a) [Lp(a)], is an independPalabras claves:Cardiovascular Risk, Lifestyle, lipoprotein(a), Physical activityAutores:Acosta L., Añez-Ramos R., Aparicio D., Arráiz N., Cano R.A., Cano-Ponce C., Colmenares C., Faria J., Finol F., Mengual-Moreno E., Peñaranda L., Pineda C., Rodriguez D., Rojas E.R., Rojas-Quintero J., Sanchez W., Sorell L.T., Toledo A.C., Urribarí J., Valmore Bermúdez, Velasco M.Fuentes:scopusOat-derived β-glucan significantly improves HDLC and diminishes LDLC and non-HDL cholesterol in overweight individuals with mild hypercholesterolemia
Conference ObjectAbstract: OBJECTIVE: To investigate the effect of bread formulated with 6 g of β-glucan (oat soluble fiber) onPalabras claves:HDL cholesterol, LDL cholesterol, LDL cholesterol/HDL cholesterol ratio, Non-HDL cholesterol, Oat soluble fiber, Total cholesterol/HDL cholesterol ratio, β-glucanAutores:Arias N., Arráiz N., Cano-Ponce C., Hernández-Hernandez R., Inglett G.E., Israili Z.H., Leal-Gonzalez E., Mengual-Moreno E., Reyna-Villasmil N., Souki-Rincón A., Valasco M., Valmore BermúdezFuentes:scopusHomeostasis model assessment (HOMA) as surrogate insulinization criteria in patients with type 2 diabetes
ArticleAbstract: Type 2 diabetes mellitus is a metabolic disorder that results from defects in both insulin secretionPalabras claves:Free fatty acids, HOMA, Insulin, Insulin Resistance, Type 2 Diabetes mellitusAutores:Acosta K., Aparicio D., Arráiz N., Bermúdez F.A., Briceño C., Bustamante M., Cabrera M., Cano R.A., Cano-Ponce C., Gómez J., Hernández-Hernandez R., Joselyn Zula, Leal E.M., Manuel V., Mengual-Moreno E., Rodriguez M., Valdelamar L., Valmore BermúdezFuentes:googlescopusLipoprotein (a) in an urban population of Venezuela: Evidence that estrogenic deprivation increase in lipoprotein (A) levels is transitory
ArticleAbstract: Background: Lipoprotein (a) [Lp (a)] is an independent risk factor for coronary artery disease and nPalabras claves:Apo (a), Hormonal replacement therapy, Lipoprotein (a), risk factor, Tissue plasminogen activatorAutores:Amell De Díaz A., Cabrera De Bravo M.C., Cano-Ponce C., Leal-Gonzalez E., Lemus-Antepaz M., Mengual-Moreno E., Sorell Gómez L., Valmore BermúdezFuentes:scopusSerum levels of lipoprotein(a) and its behavior in the state of Zulia: 10 Years of research
ReviewAbstract: Lipoprotein Lp(a) is considered one of the most important independent risk factors for atherosclerotPalabras claves:Cardiovascular disease, Coronary artery disease, Hormone replacement therapy, lipoprotein(a), myocardial infarction, Physical activity, risk factorAutores:Amell A., Añez-Ramos R., Arias F.B., Arráiz N., Cabrera M., Cano-Ponce C., Cruz S., González M.C., Mejías J.C., Mengual-Moreno E., Nava A., Rojas-Quintero J., Silva C., Sorell G L., Souki-Rincón A., Toledo A.C., Torres W., Torres Y., Valmore BermúdezFuentes:scopusVariations of lipoprotein(a) levels in the metabolic syndrome: A report from the Maracaibo City metabolic syndrome prevalence study
ArticleAbstract: Background. Lipoprotein(a) [Lp(a)] is a known risk factor for cardiovascular disease, yet its influePalabras claves:Autores:Aguirre M.A., Añez-Ramos R., Bello L.M., Cabrera M., Cano R.A., Cano-Ponce C., Chávez-Castillo M., González M.C., Lubo A., Martínez M.S., Mejías J.C., Mengual-Moreno E., Montiel M., París R., Quevedo A., Rojas L., Rojas-Quintero J., Salazar-Vílchez J., Sánchez De Rosales M., Toledo A.C., Torres W., Torres Y., Valmore Bermúdez, Villalobos M.Fuentes:scopusPrevalence of different lipid profile abnormalities in the consultation of cardiovascular risk factors from the "Dr. Félix Gómez" Endocrine and Metabolic Diseases Research Center in the period from January 2006 to January 2007
ArticleAbstract: Objective: Isolated (or mixed with other dyslipidemias) low HDLc levels are risk factors for coronarPalabras claves:Cardiovascular disease, dyslipidemia, Low isolated HDLc, PREVALENCEAutores:Cano-Ponce C., Luti Y., Mengual-Moreno E., Sánchez D., Scott G., Valmore Bermúdez, Velasco M.Fuentes:scopus